Response to intravenous ajmaline: A retrospective analysis of 677 ajmaline challenges

Europace

Volumn 11, Issue 10, 2009, Pages 1345-1352

  Veltmann, Christian ^a   Wolpert, Christian ^a   Sacher, Frederic ^b   Mabo, Philippe ^c   Schimpf, Rainer ^a   Streitner, Florian ^a   Brade, Joachim ^a   Kyndt, Florence ^d   Kuschyk, Juergen ^a   Le Marec, Herve ^d   Borggrefe, Martin ^a   Probst, Vincent ^d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Ajmaline; Brugada syndrome; ECG; Familial screening; Sodium channel blocker; Syncope

Indexed keywords

AJMALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRUGADA SYNDROME; CARDIOVASCULAR PROCEDURES; CARDIOVASCULAR RESPONSE; CHILD; CONTROLLED STUDY; DEFIBRILLATOR; DIAGNOSTIC VALUE; ECG ABNORMALITY; ELECTROCARDIOGRAPHY MONITORING; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; QRS COMPLEX; SCHOOL CHILD; SEX DIFFERENCE; SIDE EFFECT; ST SEGMENT ELEVATION; SYNCOPE;

ADULT; AJMALINE; ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; FRANCE; GERMANY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR;

EID: 70349492235     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup189     Document Type: Article

References (41)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-1396
2. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-460
3. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005;2:429-440 (Pubitemid 40439292)
4. Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F et al. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 2006;27:2544-2552
5. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061-1070
6. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510-515
7. Rolf S, Bruns HJ, Wichter T, Kirchhof P, Ribbing M, Wasmer K et al. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J 2003;24:1104-1112
8. Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas GP, Spehl S et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005;2:254-260
9. Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C et al. Flecainide test in Brugada syndrome: a reproducible but risky tool. Pacing Clin Elec-trophysiol 2003;26:338-341
10. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006;17:857-864
11. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004;110: 3023-3027
12. Padrini R, Piovan D, Javarnaro A, Cucchini F, Ferrari M. Pharmacokinetics and electrophysiological effects of intravenous ajmaline. Clin Pharmacokinet 1993;25: 408-414
13. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P et al. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J 2002;23: 1648-1654
14. Batchvarov VN, Govindan M, Camm AJ, Behr ER. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome. Heart Rhythm 2009;6:625-631
15. Joshi S, Raiszadeh F, Pierce W, Steinberg JS. Antiarrhythmic induced electrical storm in Brugada syndrome: a case report. Ann Noninvasive Electrocardiol 2007; 12 :274-278
16. Morita H, Morita ST, Nagase S, Banba K, Nishii N, Tani Y et al. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003;42:1624-1631
17. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442-449
18. Delpon E, Cordeiro JM, Nunez L, Thomsen PE, Guerchicoff A, Pollevick GD et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2008;1:209-218
19. Hong K, Berruezo-Sanchez A, Poungvarin N, Oliva A, Vatta M, Brugada J et al. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A. J Cardiovasc Electrophysiol 2004;15:64-69
20. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005;112:207-213
21. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 2008;29:1670-1680
22. Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol 2006;17:1172-1176
23. Sarasin FP, Pruvot E, Louis-Simonet M, Hugli OW, Sztajzel JM, Schlapfer J et al. Stepwise evaluation of syncope: a prospective population-based controlled study. Int J Cardiol 2008;127:103-111
24. Junttila MJ, Raatikainen MJ, Karjalainen J, Kauma H, Kesaniemi YA, Huikuri HV. Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J 2004;25:874-878
25. Letsas KP, Gavrielatos G, Efremidis M, Kounas SP, Filippatos GS, Sideris A et al. Prevalence of Brugada sign in a Greek tertiary hospital population. Europace 2007;9:1077-1080
26. Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T et al. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J 2007;28:334-344 (Pubitemid 46254639)
27. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257-263
28. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-3096
29. Priori SG, Napolitano C. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-92. discussion -92.
30. Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 2005;112:279-92. discussion -92.
31. Brugada P, Geelen P, Brugada R, Mont L, Brugada J. Prognostic value of electro-physiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol 2001;12: 1004-1007
32. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-78
33. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-1347 (Pubitemid 34260426)
34. Giustetto C, Drago S, Demarchi PG, Dalmasso P, Bianchi F, Masi AS et al. Risk stratification of the patients with Brugada type electrocardiogram: a community-based prospective study. Europace 2009;11:507-513
35. Smits JP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40:350-356
36. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Brignole M et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 2000; 102:2509-2515
37. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999;100:1660-1666
38. Grant AO. Electrophysiological basis and genetics of Brugada syndrome. J Cardiovasc Electrophysiol 2005;16:S3-7.
39. Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taguchi A et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 2000; 11 :396-404.
40. Bruns HJ, Eckardt L, Vahlhaus C, Schulze-Bahr E, Haverkamp W, Borggrefe M et al. Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads. Car-diovasc Res 2002;54:58-66.
41. Miyamoto K, Yokokawa M, Tanaka K, Nagai T, Okamura H, Noda T et al. Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. Am J Cardiol 2007;99:53-57